cagrilintide patent Development of Cagrilintide, a Long-Acting Amylin Analogue Cagrilintide (10mg vials) - Peptide
Description
Bai H, et al
Despite the existence of such a simple treatment, doctors in the USA, UK, and other countries consistently deny it to patients with B12 deficiency and pernicious anemia
How long can I stay on tirzepatide with B12 safely
And then you have these big pharmaceutical companies going, look, they're making our drugs, they're violating our patent
